TABLE 1.
Antimicrobial susceptibility test results for K. pneumoniae isolate DHQP1701672
| Antimicrobial agent | Minimum inhibitory concentration (μg/ml) | Interpretationa |
|---|---|---|
| Amikacin | ≤1 | S |
| Ampicillin | >32 | R |
| Aztreonam | 8 | I |
| Cefotaxime | 4 | R |
| Ceftriaxone | >32 | R |
| Ceftazidime | ≤1 | S |
| Ceftazidime-avibactam | ≤0.5 | S |
| Cefepime | 2 | S |
| Ciprofloxacin | ≤0.25 | S |
| Colistin | ≤0.25 | NWT |
| Doripenem | 1 | S |
| Ertapenem | 2 | R |
| Gentamicin | ≤0.25 | S |
| Imipenem | 2 | I |
| Levofloxacin | ≤0.125 | S |
| Meropenem | 2 | I |
| Piperacillin-tazobactam | 128/4 | R |
| Tetracycline | ≤2 | S |
| Tigecycline | ≤0.5 | S |
| Trimethoprim-sulfamethoxazole | ≤0.5 | S |
a
Interpretative criteria were applied according to CLSI document M100 (14), except for tigecycline, for which criteria established by the U.S. Food and Drug Administration were used. NWT, non-wild type; R, resistant; S, susceptible.